346
Views
97
CrossRef citations to date
0
Altmetric
Original Research

Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA

, , , , , , & show all
Pages 1223-1233 | Published online: 11 Feb 2015

References

  • JemalAThunMJRiesLAAnnual report to the nation on the tatus of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco controlJ Natl Cancer Inst2008100231672169419033571
  • TekadeRKDuttaTTyagiABhartiACDasBCJainNKSurface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategyJ Drug Target2008161075877218985508
  • TaratulaOKuzmovAShahMGarbuzenkoOBMinkoTNanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNAJ Control Release2013171334935723648833
  • KanapathipillaiMBrockAIngberDENanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironmentAdv Drug Deliv Rev201479C–80C107118
  • HuCMZhangLNanoparticle-based combination therapy toward overcoming drug resistance in cancerBiochem Pharmacol20128381104111122285912
  • ByrneJDBetancourtTBrannon-PeppasLActive targeting schemes for nanoparticle systems in cancer therapeuticsAdv Drug Deliv Rev200860151615162618840489
  • GandhiNS1TekadeRK2ChouguleMBNanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advancesJ Control Release201419423825625204288
  • ChengD1CaoNChenJYuXShuaiXMultifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in ratBiomaterials20123341170117922061491
  • DoktorovovaSSoutoEBSilvaAMNanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – a systematic review of in vitro dataEur J Pharm Biopharm201487111824530885
  • MaCCHeZYXiaSα,ω-cholesterol-functionalized low molecular weight polyethylene glycol as a novel modifier of cationic liposomes for gene deliveryInt J Mol Sci20141511203392035425383677
  • ArgentaDFde MattosCBMisturiniFDFactorial design applied to the optimization of lipid composition of topical antiherpetic nanoemulsions containing isoflavone genisteinInt J Nanomedicine201494737474725336951
  • SteelandtJSalmonDGilbertEAntimicrobial nanocapsules: from new solvent-free process to in vitro efficiencyInt J Nanomedicine201494467447425278751
  • SSSAKrishnamoorthyKRajappanMNanosponges: a novel class of drug delivery system – reviewJ Pharm Pharm Sci201215110311122365092
  • MouraCCSegundoMANevesJDReisSSarmentoBCo-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic applicationInt J Nanomedicine201494911492225364249
  • LiuDZhangNCancer chemotherapy with lipid-based nanocarriersCrit Rev Ther Drug Carrier Syst201027537141721083528
  • SelvamuthukumarSVelmuruganRNanostructured lipid carriers: a potential drug carrier for cancer chemotherapyLipids Health Dis20121115923167765
  • ZhangXGMiaoJDaiYQDuYZYuanHHuFQReversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cellsInt J Pharm20083611–223924418586075
  • HongMZhuSJiangYNovel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticlesJ Control Release20101411222919735683
  • HanYZhangYLiDChenYSunJKongFTransferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicinInt J Nanomedicine201494107411625187713
  • ChiuRYTsujiTWangSJWangJLiuCTKameiDTImproving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targetingJ Control Release2014180334124524898
  • DanielsTRBernabeuERodríguezJAThe transferrin receptor and the targeted delivery of therapeutic agents against cancerBiochim Biophys Acta20121820329131721851850
  • KakimotoSMoriyamaTTanabeTShinkaiSNagasakiTDual-ligand effect of transferrin and transforming growth factor alpha on polyethyleneimine-mediated gene deliveryJ Control Release2007120324224917574290
  • PercheFPatelNRTorchilinVPAccumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid modelJ Control Release201216419510222974689
  • SawantRRSriramanSKNavarroGBiswasSDalviRATorchilinVPPolyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene deliveryBiomaterials201233153942395122365809
  • PatilYBSwaminathanSKSadhukhaTMaLPanyamJThe use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistanceBiomaterials201031235836519800114
  • XuZZhangZChenYChenLLinLLiYThe characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma modelBiomaterials201031591692219846217
  • WangXLiSShiYThe development of site-specific drug delivery nanocarriers based on receptor mediationJ Control Release201419313915324862317
  • ArbuckSGChristianMCFishermanJSClinical development of TaxolJ Natl Cancer Inst Monogr19931511247912517
  • Journo-GershfeldGKappDShamayYKopečekJDavidAHyaluronan oligomers-HPMA copolymer conjugates for targeting paclitaxel to CD44-overexpressing ovarian carcinomaPharm Res20122941121113322350800
  • SouzaLGSilvaEJMartinsALDevelopment of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged releaseEur J Pharm Biopharm201179118919621352915
  • JiangZSunCYinZComparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systemsInt J Nanomedicine201272019203122619539
  • KongFZhouFGeLLiuXWangYMannosylated liposomes for targeted gene deliveryInt J Nanomedicine201271079108922393297
  • YuWLiuCLiuYZhangNXuWMannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophagesPharm Res20102781584159620422265
  • ZhangXGMiaoJDaiYQDuYZYuanHHuFQReversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cellsInt J Pharm20083611–223924418586075
  • YangXYLiYXLiMZhangLFengLXZhangNHyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancerCancer Lett2013334233834522776563
  • WangYMaYZhengYIn vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicityInt J Pharm20134411–272873523089583
  • YuanLLiuCChenYZhangZZhouLQuDAntitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer modelInt J Nanomedicine201384339435024235831
  • KawakamiSHaradaASakanakaKIn vivo gene transfection via intravitreal injection of cationic liposome/plasmid DNA complexes in rabbitsInt J Pharm2004278225526215196630
  • BartfeldNSLawJHIsolation and molecular cloning of transferrin from them tobacco hornworm, Manduca sexta. Sequence similarity to the vertebrate transferrinsJ Biol Chem19902653521684216912254322
  • KimTHJoYGJiangHHPEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targetingJ Control Release2012162242242822824780
  • RahmanHSRasedeeAHowCWZerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effectInt J Nanomedicine201382769278123946649
  • FangYPLinYKSuYHFangJYTryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: the effects of solid lipid/liquid lipid ratios in the inner coreChem Pharm Bull (Tokyo)201159226627121297310
  • De JongWHBormPJDrug delivery and nanoparticles: applications and hazardsInt J Nanomedicine20083213314918686775
  • WangCZFuYCJianSCSynthesis and characterization of cationic polymeric nanoparticles as simvastatin carriers for enhancing the osteogenesis of bone marrow mesenchymal stem cellsJ Colloid Interface Sci201443219019925086394
  • Rabinovich-GuilattLCouvreurPLambertGDubernetCCationic vectors in ocular drug deliveryJ Drug Target2004129–1062363315621688
  • Harush-FrenkelORozenturEBenitaSAltschulerYSurface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cellsBiomacromolecules20089243544318189360
  • KaurRChitandaJMMichelDLysine-functionalized nanodiamonds: synthesis, physiochemical characterization, and nucleic acid binding studiesInt J Nanomedicine201273851386622904623
  • HuangYYangTZhangWA novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivoInt J Nanomedicine201494581459525302024
  • GaoHLiuJYangCThe impact of PEGylation patterns on the in vivo biodistribution of mixed shell micellesInt J Nanomedicine201384229424624235825
  • BondìMLCraparoEFGiammonaGNanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studiesDrug Deliv2007142617717364869
  • BoylanNJSukJSLaiSKHighly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluationJ Control Release20121571727921903145
  • BiswasSDeshpandePPNavarroGDodwadkarNSTorchilinVPLipid modified triblock PAMAM-based nanocarriers for siRNA drug co-deliveryBiomaterials20133441289130123137395
  • Bedu-AddoFKHuangLInteraction of PEG-phospholipid conjugates with phospholipid: implications in liposomal drug deliveryAdv Drug Del Rev1995162–3235247